Summary: This article dives deep into how DXC Technology’s (NYSE: DXC) valuation stacks up against its peers in the IT services sector. We’ll use my own experience digging through financial reports, sprinkle in some industry expert views, and pull real-world data from sources like Yahoo Finance, S&P Global, and actual investor threads. Along the way, I’ll highlight quirks in comparing valuations, show practical steps (with screenshots you’d actually see), and wrap up with a usable summary and next steps for investors. If you want to know whether DXC is undervalued or overvalued compared to Accenture, Cognizant, Infosys, and others—this is for you.
Let’s get straight to the itch: You want to know if buying DXC stock is a bargain or a blunder compared to its rivals. The problem? Valuation is more slippery than it seems. Sure, you can look at a P/E ratio or EV/EBITDA, but if you don’t know where those numbers come from (or what they hide), you’re flying blind.
In my own experience—like the time I tried to compare DXC to Accenture and got tripped up because DXC had a big restructuring charge that year—these numbers only tell part of the story. That’s why I always cross-check with industry reports, forums (like the Value Investors Club), and actual filings. Because, believe me, there are always caveats.
First things first, I hit up Yahoo Finance and S&P Capital IQ for the latest stats. Here’s what you’ll usually look at:
But here’s the catch: DXC’s earnings are often volatile, thanks to restructuring, divestitures, and write-downs. When I first pulled up their numbers, I almost fell off my chair at how low the P/E looked—until I realized it was distorted by a one-off gain. That’s why I always check the “adjusted” numbers in the investor presentation (see below for what that looks like in the wild):
It’s tempting to lump all IT services companies together, but that’s a rookie move. Accenture (ACN), Cognizant (CTSH), Infosys (INFY), and Wipro (WIT) all have different business mixes. For this comparison, I use:
Why not just compare to Accenture? Because, as an industry analyst pointed out on an S&P Global webinar last year, “DXC is more turnaround than growth stock.” It’s like comparing a fixer-upper to a luxury condo—you need to adjust your expectations.
Here’s a table from my last Excel session, updated with May 2024 data:
Company | P/E (TTM) | EV/EBITDA | P/B | Free CF Yield |
---|---|---|---|---|
DXC | 13.4 | 5.1 | 1.07 | ~12% |
Accenture (ACN) | 28.2 | 19.0 | 7.95 | ~4% |
Cognizant (CTSH) | 16.8 | 11.2 | 2.63 | ~7% |
Infosys (INFY) | 23.9 | 17.5 | 7.11 | ~5% |
IBM | 20.7 | 12.4 | 6.19 | ~7% |
Source: Yahoo Finance, S&P Capital IQ, May 2024
At this point, the numbers scream “undervalued!” But it’s never that simple. On the Value Investors Club, one poster broke it down: “DXC’s valuation is cheap, yes, but that reflects execution risk. You’re not getting a discount for nothing.”
Meanwhile, S&P Global’s sector report (April 2024) warns, “The lower multiples reflect legacy business risks and uncertain turnaround prospects.” So, you get what you pay for.
I remember talking with a fund manager last fall who summed it up perfectly: “I bought DXC at 0.8x book, thinking it was a deep value play. But every quarter, there’s another write-down or missed target. Meanwhile, Accenture keeps chugging along, but you pay 7x book for that steadiness. It’s a classic risk/reward trade.”
He actually ran a model comparing their next-12-month EBITDA estimates and concluded that if DXC hit just average sector margins, its stock would double. But, as he said, “That’s a big if.”
DXC’s business is heavy on legacy IT outsourcing, so its growth profile is weaker than cloud-first peers. Accenture, Infosys, and Cognizant have more of their revenue in digital transformation—the hot spot for margins and growth. That explains a lot of the valuation gap.
DXC’s free cash flow yield looks amazing on paper (~12%), but that’s partly because their stock price has lagged hard. If you dig into their filings (see their Q1 2024 10-Q), you’ll spot big swings in working capital and one-off cash outs (restructuring, etc.). In short: The cash is real, but not always recurring.
There’s no global law on how to “value” an IT services firm, but U.S. GAAP and IFRS both require fair value measurement and transparent disclosure (see FASB ASC 820). The SEC polices what’s in the filings, but the market sets the price.
Country/Region | Valuation Standard Name | Legal Basis | Enforcement Body | Notes |
---|---|---|---|---|
USA | FASB ASC 820 (Fair Value Measurement) | Sarbanes-Oxley Act, SEC Reg S-X | SEC | Strict disclosure, regular audits |
EU | IFRS 13 (Fair Value Measurement) | EU Accounting Directive | ESMA / Local regulators | Harmonized, but local enforcement varies |
India | Ind AS 113 (Fair Value Measurement) | Companies Act 2013 | SEBI | IFRS-aligned, local nuances |
References: FASB ASC 820, IFRS 13
I’ll be honest: The first time I ran a screen for “cheap tech services,” DXC looked like a screaming buy. But after reading through their earnings call transcripts (pro tip: always check the Q&A for hard questions), I realized there’s a reason for the discount. Every time management promised a turnaround, another restructuring popped up next quarter. That’s why I started looking at free cash flow over several years, not just one.
In my own portfolio, I’ve kept DXC as a small “special situations” bet, but I overweight more stable names like Accenture and Infosys. For me, valuation alone isn’t enough—you need to see a clear path to improvement and believe in management’s story.
Bottom line: By the numbers, DXC is undervalued compared to its peers. Its P/E, EV/EBITDA, and price/book ratios are all much lower than industry averages, and the free cash flow yield is impressive. But—and this is a big but—those low multiples reflect real risks: legacy business, execution uncertainty, and a patchy track record. There’s upside if the turnaround works, but it’s not a slam dunk.
For investors, my advice: Don’t just chase the cheapest number. Dig into the story, cross-check what management says with what actually happens, and size your bets accordingly. If you want steady, Accenture or Infosys might be better. If you’re a value hunter with a strong stomach, DXC could be your kind of play—but go in with your eyes open.
And if you ever catch yourself thinking “Wow, this is cheap!”—double-check what the market might know that you don’t. That’s a lesson I learned the hard way.
Author background: 10+ years in equity research and investment analysis, with a focus on technology and business services. All data and cited sources are current as of May 2024.